Contract HT942523C0078
Hexamer Therapeutics Inc. · Department Of Defense · November 25, 2025
Hexamer Therapeutics Inc. was awarded a federal contract by Department Of Defense (Defense Health Agency) on November 25, 2025 for $3.93 million (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Pullman, WA. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $3.93 million.
Contract details
- PIID
- HT942523C0078
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Basic Research
- Place of performance
- Pullman, WA
- First action
- November 25, 2025
Description
SELF-ASSEMBLING, MOLECULAR CARRIER VACCINE PLATFORM FOR DEPLOYMENT DURING AN INFECTIOUS DISEASE PANDEMIC. HIGHLY MODULAR IN THAT DIFFERENT TARGETS CAN RAPIDLY BE COUPLED TO THE SCAFFOLD TO MODIFY A CURRENT VACCINE OR MAKE A COMPLETELY NEW ONE.
Modification timeline
-
November 25, 2025Mod P00003 · Supplemental Agreement For Work Within Scope$3.93M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Avian, Llc | Department Of Defense | December 31, 2025 | $54.05M |
| Rtx Bbn Technologies, Inc. | Department Of Defense | December 29, 2025 | $4.36M |
| Council On Strategic Risks (The) | Department Of Defense | December 23, 2025 | $356.6K |
| Eagle Integrated Services, Llc | Department Of Defense | December 23, 2025 | $1.93M |
| Ssi-Venesco Jv Llc | Department Of Defense | December 23, 2025 | $144.5K |
| Techwerks Llc | Department Of Defense | December 23, 2025 | $2.21M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HT942523C0078?
Contract HT942523C0078 is a federal contract awarded to Hexamer Therapeutics Inc. by Department Of Defense on November 25, 2025 for $3.93 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract HT942523C0078?
Hexamer Therapeutics Inc. won contract HT942523C0078 from Department Of Defense.
How much is contract HT942523C0078 worth?
Contract HT942523C0078 has obligated $0 to date but carries a potential ceiling of $3.93 million if fully funded and all options are exercised.